Rapirosiran is an N-acetylgalactosamine-conjugated small interfering RNA that specifically targets mRNA of hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) in the liver. Inhibition of HSD17B13 via Rapirosiran is associated with a reduced risk of chronic liver disease. This reagent is valuable for investigating the mechanisms of non-alcoholic steatohepatitis and exploring potential therapeutic approaches.
Rapirosiran is an N-acetylgalactosamine-conjugated small interfering RNA that specifically targets mRNA of hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) in the liver. Inhibition of HSD17B13 via Rapirosiran is associated with a reduced risk of chronic liver disease. This reagent is valuable for investigating the mechanisms of non-alcoholic steatohepatitis and exploring potential therapeutic approaches.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
